Company / Interest Expense per Share
Akebia Therapeutics, Inc. Interest Expense per Share History
FY2014-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-$0.03
FY2015
5-year range
-
FY2014-FY2015
Trend
+97.1%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-0.03 in FY2015.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, interest expense per share increased 97.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2015 | -$0.03 | +97.1% |
| FY2014 | -$1.19 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026